4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-23-029599
Chief Financial Officer acquired 22,436 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gerber Brianna · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-12 | Exercise or conversion : show line 1 in the form | +22,436 | 22,436 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-12 | Exercise or conversion : show line 2 in the form Restricted Stock Unit | −22,436 | 44,872 | D |
Loading xslF345X05/wk-form4_1692148297.xml…